Recombinant factor VIII (Kogenate) treatment of previously untreated patients (PUPS) with haemophilia A: Update of safety, efficacy and inhibitor development after seven study years. - Lusher, J; Arkin, S; Abildgaard, D; Hurst, D (1997)
(abstr); June suppl